HIV-INFECTED INTRAVENOUS-DRUG-USERS IN METHADONE-MAINTENANCE TREATMENT - CLINICAL PROBLEMS AND THEIR MANAGEMENT

被引:8
|
作者
FERRANDO, SJ [1 ]
BATKI, SL [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO, SCH MED, SAN FRANCISCO, CA 94143 USA
关键词
AIDS; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG USERS; METHADONE MAINTENANCE TREATMENT; PSYCHIATRIC DISORDERS; TRIPLE DIAGNOSIS;
D O I
10.1080/02791072.1991.10472238
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Infection with the human immunodeficiency virus (HIV) is a significant and growing problem among intravenous drug users (IVDUs), both from the standpoint of personal morbidity and public health concerns regarding spread of the virus. Most HIV infected IVDU s are opioid addicts. The most common form of long-term treatment of opioid dependence is methadone maintenance treatment (MMT). MMT can therefore play an important role in both AIDS prevention and reduction of HIV-related morbidity through diminishing drug use, promoting a healthier life-style, and providing direct medical and psychiatric care. Attempts to manage patients with a triple diagnosis of drug abuse, medical, and psychiatric problems can pose significant clinical challenges, requiring the efforts of a multidisciplinary team. The management of HIV-infected patients in MMT is discussed and case examples from the MMT program of the San Francisco General Hospital Substance Abuse Services are presented to illustrate useful strategies in the care of these complicated patients. © 1991 Taylor & Francis Group, LLC.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 50 条
  • [1] METHADONE AND AIDS - ARE METHADONE-MAINTENANCE TREATMENT PROGRAMS (MMTPS) APT TO PREVENT HIV INFECTIONS AMONG INTRAVENOUS-DRUG-USERS
    BOCKER, FM
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 1992, 6 (04): : 197 - 206
  • [2] A CONTROLLED TRIAL OF METHADONE-MAINTENANCE IN A POPULATION OF INTRAVENOUS-DRUG-USERS IN BANGKOK - IMPLICATIONS FOR PREVENTION OF HIV
    VANICHSENI, S
    WONGSUWAN, B
    CHOOPANYA, K
    WONGPANICH, K
    [J]. INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1991, 26 (12): : 1313 - 1320
  • [3] IMMUNOLOGICAL ALTERATIONS IN SPLENECTOMIZED HIV-INFECTED INTRAVENOUS-DRUG-USERS
    MIENTJES, GHC
    MIEDEMA, F
    VANDENHOEK, JAR
    COUTINHO, RA
    [J]. AIDS, 1994, 8 (02) : 269 - 271
  • [5] CLINICAL MANAGEMENT OF HIV DISEASE IN INTRAVENOUS-DRUG-USERS
    SHERRARD, JS
    BINGHAM, JS
    ONEN, TS
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1993, 4 (05) : 254 - 260
  • [6] SERUM-ALBUMIN AND OTHER PARAMETERS IN HIV-INFECTED INTRAVENOUS-DRUG-USERS
    CIRASINO, L
    LANDONIO, G
    IMBRIANI, M
    RAGAINI, S
    [J]. JOURNAL OF INFECTION, 1993, 26 (02) : 229 - 232
  • [7] AMBIVALENCE TOWARD METHADONE TREATMENT AMONG INTRAVENOUS-DRUG-USERS
    ROSENBLUM, A
    MAGURA, S
    JOSEPH, H
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 1991, 23 (01) : 21 - 27
  • [8] HIV IN INTRAVENOUS-DRUG-USERS
    DAWSON, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (09): : 632 - 632
  • [9] Improved antiretroviral adherence and HIV treatment outcomes among HIV-infected drug users enrolled in methadone maintenance therapy
    Palepu, A
    Tyndall, MW
    Joy, R
    Kerr, T
    Press, N
    Wood, E
    Montaner, JS
    Hogg, R
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 117 - 117
  • [10] IMMUNE SERUM MARKERS AND CD4 CELL COUNTS IN HIV-INFECTED INTRAVENOUS-DRUG-USERS
    CHAISSON, RE
    TAYLOR, E
    MARGOLICK, JB
    MUNOZ, A
    SOLOMON, L
    COHN, S
    NELSON, KE
    VLAHOV, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (05): : 456 - 460